• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 2, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume2, Issue2

Melanoxoin reduces tumor growth in xenograft animial model and inhibits cell migration in human lung cancer cell lines.

    Chieh-Yu Peng Shou-Fang Wu Hsiu-Yi Hung Yang-Chang Wu

European Journal of Molecular & Clinical Medicine, 2015, Volume 2, Issue 2, Pages -

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Natural products remain the best sources of drugs and drug leads. Various anticancer drugs are derived from the natural products. In our previous studies, we found that methanol extract of Pterocarpus santalinus exhibited potent cytotoxicity and anti-inflammatory activities. Among the series of compounds isolated from Pterocarpus santalinus, melanoxoin demonstrated the highest cytotoxic effects with a IC50 of 1.98 μg/ml in human non-small cell lung cancer H1299 cells. The results showed that melanoxoin regulated the transcription of several cell cycle regulators in H1299 cells. Melanoxoin induced tubulin depolymerization, suggesting that melanoxoin causes G2/M arrest thus increasing apoptosis in tumor cell. The results of neutral comet assay showed that treatment with melanoxoin induced significant DNA damage in H1299 cells, while the in vivo efficacy of melanoxoin was revealed by the mice xenograft models. Clinical data showed that an increase (61%) of MET expression was observed in non-small cell lung cancer samples compared with adjacent normal tissues.
Keywords:
    HGF/c Met signaling is involved in the cancer progression metastasis and gefitnib resistance. In particular we also found that melanoxoin can inhibit HGF induced cell migration using the wound healing and transwell migration assay. Altogether it exerted great potential to be developed into novel anti cancer agent
  • PDF (59 K)
  • XML
(2015). Melanoxoin reduces tumor growth in xenograft animial model and inhibits cell migration in human lung cancer cell lines.. European Journal of Molecular & Clinical Medicine, 2(2), -.
Chieh-Yu Peng; Shou-Fang Wu; Hsiu-Yi Hung; Yang-Chang Wu. "Melanoxoin reduces tumor growth in xenograft animial model and inhibits cell migration in human lung cancer cell lines.". European Journal of Molecular & Clinical Medicine, 2, 2, 2015, -.
(2015). 'Melanoxoin reduces tumor growth in xenograft animial model and inhibits cell migration in human lung cancer cell lines.', European Journal of Molecular & Clinical Medicine, 2(2), pp. -.
Melanoxoin reduces tumor growth in xenograft animial model and inhibits cell migration in human lung cancer cell lines.. European Journal of Molecular & Clinical Medicine, 2015; 2(2): -.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 40
  • PDF Download: 74
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus